EyePoint Pharmaceuticals Inc officer, DAVID S JONES, is set to sell 34,442 shares of common stock on 01/24/2024, as per the latest SEC filings. The shares, valued at approximately $857,950.22, were acquired on the same day through the exercise of stock options, with payment made in cash to the issuer. This transaction follows a recent history of sales by JONES over the past three months, totaling 35,066 shares for gross proceeds of $795,191.34.
EyePoint Pharmaceuticals Inc officer, DAVID S JONES, is set to sell 34,442 shares of common stock on 01/24/2024, as per the latest SEC filings. The shares, valued at approximately $857,950.22, were acquired on the same day through the exercise of stock options, with payment made in cash to the issuer. This transaction follows a recent history of sales by JONES over the past three months, totaling 35,066 shares for gross proceeds of $795,191.34.